Cardiovascular diseases: protective effects of melatonin.
about
Disturbed tryptophan metabolism in cardiovascular diseaseHypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin.Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes.Myocardial ischemia-reperfusion injury: Possible role of melatoninPeripheral and central effects of melatonin on blood pressure regulationEffects of circadian disruption on the cardiometabolic system.Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits.Safflor yellow A protects neonatal rat cardiomyocytes against anoxia/reoxygenation injury in vitro.Effects of melatonin on the proliferation and apoptosis of sheep granulosa cells under thermal stress.Potency of melatonin in living beingsmtDNA T8993G mutation-induced F1F0-ATP synthase defect augments mitochondrial dysfunction associated with hypoxia/reoxygenation: the protective role of melatoninMelatonin membrane receptors in peripheral tissues: distribution and functionsEffect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial.The effect of preoperative melatonin on nuclear erythroid 2-related factor 2 activation in patients undergoing coronary artery bypass grafting surgeryRotating night shift work and the risk of ischemic stroke.Endothelium and its alterations in cardiovascular diseases: life style intervention.Type 2 diabetes and cardiovascular disease: what next?Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.Role of simvastatin and RORα activity in the macrophage apoptotic pathway.Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA/CD147 signaling pathway.A comparison of melatonin and α-lipoic acid in the induction of antioxidant defences in L6 rat skeletal muscle cells.Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study.Different prevalence of chronic-non-infectious diseases.Circadian Rhythm Disruption and Subsequent Neurological Disorders in Night-Shift Workers.Evaluating Radioprotective Effect of Hesperidin on Acute Radiation Damage in the Lung Tissue of Rats.Changes in crevicular cytokines after application of melatonin in patients with periodontal disease.The Angiotensin-melatonin axis.Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.A Pre-Exercise Dose of Melatonin Can Alter Substrate Use During Exercise.Melatonin Efficacy in Obese Leptin-Deficient Mice Heart.Low shear stress upregulates the expression of fractalkine through the activation of mitogen-activated protein kinases in endothelial cells.Melatonin signaling in mitochondria extends beyond neurons and neuroprotection: Implications for angiogenesis and cardio/gastroprotection.Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition
P2860
Q27010486-371B4787-4CF0-4144-AA51-BE1B10EE5997Q33930296-3156F7C6-F230-4D7F-B68C-89855EA74971Q34029266-561BD2D3-B09D-4491-885E-FAD3DFD7245FQ34390698-18E82AEB-7D87-4F7F-947B-9ED56B66CD64Q34486692-A8C7A1EE-C644-4E88-8A5B-23FAD64F208EQ34520468-8CE5154C-4F67-4FBB-A0F2-DB78A0F5E015Q34540863-AA572F40-E64C-43F5-96EE-2EC49AB4ED8BQ34581832-D677939C-B307-48EA-B250-5E199B5DEE8EQ34685634-2DF6E2B2-E628-4C81-AC38-FBF3BA5B0154Q34804952-AA43A338-0758-4AE5-8F27-E9B27E15C973Q35060592-E6AC0F5F-0275-4B80-9302-5083375B7E96Q35784330-111F2836-3D51-4DCA-9D79-BC52E14054F9Q35897901-CA9BF295-26B8-4CF4-B87D-DB4EF2C72715Q36831068-2995037C-5B50-43DF-8504-5C903C06BBA2Q37306170-0346D09F-D82A-4FB5-A7F8-B2997DDC7159Q37639902-7B6F22E6-4F2F-42A0-96AD-F232F7EA11B0Q38191133-68F04904-3714-4DDA-A33D-BC59F75F14FDQ38199493-AEAD16A8-5392-4EA4-9445-998FECD17DA3Q38726115-44DFF382-3BBC-4B55-B4F5-B02CC80983C0Q38748509-06CABAD2-8871-450D-8AB3-00322CAA9CAAQ40981313-358F24AC-7794-431E-9487-FC1B8EF802E1Q41573017-BE42519A-CEC8-4DD7-83CF-146E3A62BE51Q41849867-3BF33DA4-8396-47A4-A2CC-71EAEEE89EEBQ42365799-433A0A0F-BDA7-45CE-9C88-A7445E3BA4C8Q42369621-143C688C-88F9-468F-ACAF-C1B561EA9DD4Q42662808-BAC1D79B-C26E-4CF2-8BFE-C9853E6BBF19Q43017975-6958A768-E215-4870-9EC6-1743FD460DC6Q46183692-8BC61E45-C6A9-42C9-8092-899C7D3BD8CFQ47093897-34068012-6C2E-4838-917C-EEE7621929FFQ47163241-5811C360-EB53-49BD-AD79-3E28AA77C0E3Q49926375-71424C5A-79CB-46D7-9C7A-900B7A9D9DA0Q50026622-65718CFB-AB6F-4E05-9E87-7F0A347FB68AQ58764473-D84511E6-CA30-4EF6-AE8D-2E2FA6D4A06B
P2860
Cardiovascular diseases: protective effects of melatonin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular diseases: protective effects of melatonin.
@en
Cardiovascular diseases: protective effects of melatonin.
@nl
type
label
Cardiovascular diseases: protective effects of melatonin.
@en
Cardiovascular diseases: protective effects of melatonin.
@nl
prefLabel
Cardiovascular diseases: protective effects of melatonin.
@en
Cardiovascular diseases: protective effects of melatonin.
@nl
P2093
P2860
P1476
Cardiovascular diseases: protective effects of melatonin.
@en
P2093
Dun-Xian Tan
M Pilar Terron
Rita Rezzani
Russel J Reiter
Sandra Tengattini
P2860
P356
10.1111/J.1600-079X.2007.00518.X
P577
2008-01-01T00:00:00Z